Immunology of Infectious Disease News 6.46 November 21, 2018 | |
| |
TOP STORYAlarmin S100A11 Initiates a Chemokine Response to the Human Pathogen Toxoplasma gondii By applying an unbiased biochemical screening approach, investigators showed that human monocytes recognized the presence of T. gondii infection by detecting the alarmin S100A11 protein, which is released from parasite-infected cells via caspase-1-dependent mechanisms. [Nat Immunol] Abstract | |
| |
PUBLICATIONS(Ranked by impact factor of the journal)Researchers present the first application of the Spec-seq framework, which they applied to human plasmablasts after influenza vaccination in order to characterize transcriptional differences governed by B cell receptor isotype and vaccine reactivity. [J Clin Invest] Full Article Scientists utilized invasive and non-invasive Salmonella strains combined with single-cell RNA-sequencing to study the transcriptome of individual infected and bystander monocyte-derived dendritic cells implicated in disseminating invasive ST313. [Nat Commun] Full Article Schizophrenia Is Associated With an Aberrant Immune Response to Epstein-Barr Virus Individuals with schizophrenia had marked elevations in the levels of antibodies to Epstein-Barr virus (EBV) virions as compared to the control population. Further analyses indicated increased levels of reactivity to EBV-viral capsid antibody but not to EBV nuclear antigen-1 or to other human herpesviruses. [Schizophr Bull] Abstract | Press Release Investigators evaluated the role of CD8+ T cells during chronic T. cruzi infection, with a focus on sites of pathogen persistence. Consistent with repetitive antigen exposure during chronic infection, parasite-specific CD8+ T cells from multiple organs expressed high levels of KLRG1, but exhibited a preferential accumulation of CD69+ cells in skeletal muscle, indicating recent antigen encounter in a niche for T. cruzi persistence. [PLoS Pathog] Full Article Developmental Induction of Human T-Cell Responses against Candida albicans and Aspergillus fumigatus Scientists showed that antifungal T-cell responses are vigorously initiated within the first years of life against lysates and peptides of C. albicans or A. fumigatus, presented by autologous monocytes. [Sci Rep] Full Article Researchers investigated how C. krusei mannan affected dendritic cell (DC) responses in comparison to C. albicans, C. tropicalis and C. glabrata mannan. They showed that only C. krusei mannan induced massive cytokine responses in DCs, and led to apoptosis. [Sci Rep] Full Article The authors constructed a novel multi-epitope based vaccine against leptospirosis by using Hap1, LigA, LAg42, SphH and HSP58 antigens. T cell and IFN gamma epitopes were predicted from these antigens. [Mol Immunol] Abstract | Graphical Abstract Immune Activation and Regulatory T Cells in Mycobacterium tuberculosis Infected Lymph Nodes Scientists analyzed T regulatory cells frequency and activation along with CD4+ T cell function in lymph nodes from lymph node tuberculosis patients. Lymph node mononuclear cells were compared to autologous peripheral blood mononuclear cells. [BMC Immunol] Full Article Researchers elucidated the activity of IL-17A in the protection against C. neoformans, an opportunistic fungus that causes fatal meningoencephalitis among AIDS patients. [BMC Immunol] Full Article Subscribe to our sister publications: Human Immunology News & Immune Regulation News. | |
| |
REVIEWSThe Monocyte-Macrophage-Mast Cell Axis in Dengue Pathogenesis Among the numerous target cells for dengue virus in humans are monocytes, macrophages and mast cells which are important regulators of vascular integrity and which undergo dramatic cellular responses after infection by dengue virus. [J Biomed Sci] Full Article Visit our reviews page to see a complete list of reviews in the immunology of infectious disease research field. | |
| |
INDUSTRY NEWSEmergent BioSolutions Inc. and Valneva SE announced positive interim results for the Phase I study evaluating VLA1601, their vaccine candidate against the Zika virus. The highly purified inactivated vaccine candidate, VLA1601, met the study’s primary endpoint showing a favorable safety profile in all doses and schedules tested. [Emergent BioSolutions Inc.] Press Release Institute for Bioscience and Biotechnology Research (IBBR) researchers recently received $3.9 million from the National Institutes of Health (NIH) to develop a multi-specific, single agent antibody therapeutic against HIV-1 to block virus infection and to clear the reservoir of HIV-infected cells from the body. [Institute for Bioscience and Biotechnology Research] Press Release USAN Council Assigns Leronlimab as the Official Name for CytoDyn’s PRO 140 CytoDyn Inc. announced that the United States Adopted Names (USAN) Council has adopted leronlimab as the official name for PRO 140. [CytoDyn Inc.] Press Release | |
| |
POLICY NEWSStop Exploitation of Foreign Postdocs in the United States A survey reveals some lab heads are using the need for visas to create unacceptable conditions for junior researchers. Some PIs are exploiting the fact that overseas scientists rely on them for continued visas. The responses suggest that senior scientists are using this reliance to force postdocs to work longer hours and endure unacceptable conditions. [Nature] Editorial To Catch Misconduct, Journals Are Hiring Research Integrity Czars Scientific journals’ creation of dedicated positions for rooting out misconduct before publication comes amid growing awareness of such issues, and stems from a recognition that spot-checking and other ad hoc arrangements were insufficient. [STAT News] Editorial French Science Behemoth Launches Research-Integrity Office France’s national research centre, the CNRS, has announced plans to create its first office of research integrity to investigate scientific misconduct and promote good research practice. [Nature News] Editorial In Reversal, NSF Lifts Proposal Limits on Biologists In a reversal, the National Science Foundation (NSF) will no longer restrict researchers to only one proposal submission per year to the biology directorate’s three core tracks in which they are listed as a principal investigator (PI) or co-PI. [ScienceInsider] Editorial
| |
EVENTSNEW STI & HIV 2019 World Congress Visit our events page to see a complete list of events in the community.
| |
JOB OPPORTUNITIESNEW Research Group Leader – Infection Biology (Max Planck Institute for Infection Biology) NEW Postdoctoral Position – Natural Killer Cells (The Scripps Research Institute) Research Scientist – Virology (ViraTherapeutics GmbH) Postdoctoral Research Associate – Bacterial Infection (University of Illinois at Chicago) Postdoctoral Research Scientist – Modeling Infection (Columbia University) Postdoctoral Position – Vaccines and Immunity (Nationwide Children’s Hospital) Postdoctoral Position – Innate Immunity, Virology (Technical University of Munich) Research Fellow – Immunology (Dana-Farber Cancer Institute) Assistant Professor – Immunology (Ragon Institute of MGH, MIT and Harvard) Recruit Top Talent: Reach potential candidates by posting your organization’s career opportunities on the Connexon Creative Job Board at no cost.
| |
Have we missed an important article or publication in Immunology of Infectious Disease News? Click here to submit! Comments or suggestions? Submit your feedback here. | |
|